Status:

RECRUITING

Cannabidiol Effects on Learning and Anxiety

Lead Sponsor:

University of Connecticut

Conditions:

Anxiety and Fear

Eligibility:

All Genders

18-50 years

Phase:

EARLY_PHASE1

Brief Summary

To examine the extent to which Cannabidiol (CBD) enhances fear conditioning extinction in college undergraduates who show elevated social anxiety. Undergraduates who display elevated social anxiety on...

Eligibility Criteria

Inclusion

  • 18-50 years of age

Exclusion

  • Difficulties seeing a computer screen
  • Anyone currently taking CBD within the last 24 hours.
  • Anyone using any cannabis product within the last 24 hours.
  • Heart problems or heart disease
  • A neurological disorder such as epilepsy, stroke, multiple sclerosis, tumor, vascular malformations, aneurysm
  • Are currently pregnant or breast-feeding

Key Trial Info

Start Date :

October 30 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

February 1 2026

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT05283382

Start Date

October 30 2024

End Date

February 1 2026

Last Update

April 18 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Connecticut

Storrs, Connecticut, United States, 06269-1020